Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease

NCT: NCT07605624 · NOT_YET_RECRUITING

NCT IDNCT07605624
StatusNOT_YET_RECRUITING
Start Date2026-05-10
Completion2029-01-31

Brief Summary

This prospective, multicenter, observational cohort study aims to establish a post-market registry framework to evaluate the real-world clinical applicability, long-term safety, and effectiveness of innovative heart valve devices in China.

Frequently Asked Questions

What is Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease?

Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease is a clinical trial registered under NCT07605624. Current status: NOT_YET_RECRUITING.

What is the status of NCT07605624?

The current status of NCT07605624 (Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease) is: NOT_YET_RECRUITING.

When did Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease start?

Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease started on 2026-05-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑